I think that maybe you can split the priorities into two sorts as well. You can talk about your national priorities, and then you can talk about your global priorities—our contribution, as Canada, to the broader world. If you're talking about global priorities we should be focusing on, we can look at the World Health Organization, which has very clear identification of some of the key issues, some of the key diseases, the key gaps, the key areas that desperately need new research and innovation around them. That's one area to look at.
I think you can also look at these international product development partnerships—like DNDi, for instance, which is identifying key priorities very much related to what's happening to patients on the ground in all of these countries, done very genuinely, without any sort of political or profit motivation behind their decisions on what they will do. They really go for the most neglected diseases.
For instance, they're now working on pediatric HIV. It's crazy, because we've been working on HIV/AIDS for years. The pediatric formulations have been extremely slow in coming, yet children are one of the largest affected parts of the population, so they said, “We have to work on this.” It was the same with my example about Chagas disease. There weren't any pediatric formulations, and this was one of the key parts of the population affected, so DNDi went to make a pediatric version, which has completely transformed the lives of so many people. I think that on a global level we can look at those kinds of priorities.
Then, as Jason said, on a national level we just need to look at the main issues affecting our Canadian population. I work in the north, in Nunavut, and I think that tuberculosis should be something extremely high on the Canadian government's agenda. We have people in our country who are suffering and dying from tuberculosis, which is absolutely unacceptable for a country as wealthy as Canada.
I think that in looking at our population health here in Canada, we can make priorities. You talk about MS. You talk about insulin. I think there are some key areas that really are affecting our population here.